|
US4237130A
(en)
*
|
1979-06-21 |
1980-12-02 |
Merck & Co., Inc. |
2,3-Dihydro-6,7-disubstituted-5-(substituted sulfonyl)benzofuran-2-carboxylic acids
|
|
ATE30722T1
(de)
*
|
1982-10-22 |
1987-11-15 |
Ciba Geigy Ag |
Neue benzodioxolderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen.
|
|
US4600709A
(en)
*
|
1982-10-22 |
1986-07-15 |
Ciba-Geigy Ag |
Benzodioxole derivatives, processes for the manufacture thereof and corresponding pharmaceutical compositions
|
|
EP0158596A3
(de)
*
|
1984-04-06 |
1986-08-13 |
Ciba-Geigy Ag |
Neue substituierte Benzodioxolderivate, Verfahren zu deren Herstellung und entsprechende pharmazeutische Zusammensetzungen
|
|
CN1014148B
(zh)
*
|
1984-09-05 |
1991-10-02 |
盐野义制药株式会社 |
2，3-二氢苯并呋喃-5-磺酰胺衍生物的制备方法
|
|
JPS6163671A
(ja)
*
|
1984-09-05 |
1986-04-01 |
Shionogi & Co Ltd |
２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤
|
|
JPH05255089A
(ja)
|
1991-12-18 |
1993-10-05 |
Sanwa Kagaku Kenkyusho Co Ltd |
抗ウイルス剤
|
|
US5464788A
(en)
*
|
1994-03-24 |
1995-11-07 |
Merck & Co., Inc. |
Tocolytic oxytocin receptor antagonists
|
|
GB9600464D0
(en)
|
1996-01-09 |
1996-03-13 |
Smithkline Beecham Plc |
Novel method
|
|
AU8253698A
(en)
|
1997-06-17 |
1999-01-04 |
Schering Corporation |
Novel tricyclic sulfonamide inhibitors of farnesyl-protein transferase
|
|
TR200002182T2
(tr)
|
1998-01-27 |
2000-12-21 |
Aventis Pharmaceuticals Products Inc. |
İkame edilmiş aksozaherosayklil faktör xa inhibitörleri
|
|
US7517884B2
(en)
*
|
1998-03-30 |
2009-04-14 |
Kalypsys Inc. |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR
|
|
MXPA01002173A
(es)
|
1998-08-28 |
2003-07-14 |
Scios Inc |
Inhibidores de p38-alfa cinasa.
|
|
CN1129581C
(zh)
*
|
1998-09-22 |
2003-12-03 |
山之内制药株式会社 |
氰基苯基衍生物
|
|
CA2367963A1
(en)
|
1999-03-22 |
2000-09-28 |
Darwin Discovery Limited |
Hydroxamic and carboxylic acid derivatives
|
|
WO2001040192A1
(en)
*
|
1999-12-03 |
2001-06-07 |
Kyoto Pharmaceutical Industries, Ltd. |
Novel heterocyclic compounds and salts thereof and medicinal use of the same
|
|
JP2001261657A
(ja)
|
2000-03-17 |
2001-09-26 |
Yamanouchi Pharmaceut Co Ltd |
シアノフェニル誘導体
|
|
GB0007907D0
(en)
|
2000-03-31 |
2000-05-17 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
JP4975941B2
(ja)
*
|
2000-09-29 |
2012-07-11 |
トポターゲット ユーケー リミテッド |
（ｅ）−ｎ−ヒドロキシ−３−（３−スルファモイル−フェニル）アクリルアミド化合物及びその治療用途
|
|
CA2433090A1
(en)
*
|
2000-12-27 |
2002-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Dipeptidyl peptidase iv inhibitor
|
|
CN1800185A
(zh)
|
2001-06-11 |
2006-07-12 |
比奥维特罗姆股份公司 |
取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ii型糖尿病的药物的应用
|
|
US7456184B2
(en)
*
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
|
NZ536116A
(en)
|
2002-04-03 |
2007-01-26 |
Topotarget Uk Ltd |
Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
|
|
US6875780B2
(en)
*
|
2002-04-05 |
2005-04-05 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods for their preparation
|
|
CN1181065C
(zh)
*
|
2002-05-08 |
2004-12-22 |
上海医药工业研究院 |
芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
|
|
EP2436676A1
(en)
*
|
2002-06-12 |
2012-04-04 |
Symphony Evolution, Inc. |
Human adam-10 inhibitors
|
|
ES2297382T3
(es)
|
2003-02-14 |
2008-05-01 |
Eli Lilly And Company |
Derivados de sulfonamida como moduladores de ppar.
|
|
WO2004092130A2
(en)
|
2003-04-07 |
2004-10-28 |
Kalypsys, Inc. |
N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
|
|
US20060258683A1
(en)
*
|
2003-04-07 |
2006-11-16 |
Liu Kevin |
Para-sulfonyl substituted phenyl compounds as modulators of ppars
|
|
DE602004002394T2
(de)
|
2003-04-17 |
2007-09-13 |
Kalypsys, Inc., San Diego |
(3-{3-'(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino]-propoxy}-phenyl)-essigsäure und verwandte verbindungen als modulatoren von ppars und verfahren zur behandlung von stoffwechselstörungen
|
|
MXPA06001202A
(es)
|
2003-07-29 |
2006-08-31 |
Xenon Pharmaceuticals Inc |
Derivados piridilo y su uso como agentes terapeuticos.
|
|
US7456180B2
(en)
|
2003-07-30 |
2008-11-25 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their use as therapeutic agents
|
|
CA2533900A1
(en)
|
2003-07-30 |
2005-02-10 |
Xenon Pharmaceuticals Inc. |
Pyridyl derivatives and their use as therapeutic agents
|
|
CA2533897A1
(en)
|
2003-07-30 |
2005-02-10 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
DE10335449A1
(de)
*
|
2003-08-02 |
2005-02-17 |
Bayer Healthcare Ag |
Bicyclische Indolinsulfonamid-Derivate
|
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
WO2005060958A1
(en)
|
2003-12-19 |
2005-07-07 |
Kalypsys, Inc. |
(5- (2-phenyl)-thiazol-5-ylmethoxy)-indol-1-yl) -acetic acid derivatives and related compounds as modulators of the human ppar-delta receptor for the treatment of metabolic disorders such as type 2 diabetes
|
|
AR048523A1
(es)
|
2004-04-07 |
2006-05-03 |
Kalypsys Inc |
Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
|
|
ATE537830T1
(de)
|
2004-07-06 |
2012-01-15 |
Xenon Pharmaceuticals Inc |
Nicotinamid derivate und ihre verwendung als therapeutika
|
|
AU2005286647A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
AU2005286790A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD)
|
|
MX2007003318A
(es)
|
2004-09-20 |
2007-05-18 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como agentes terapeuticos.
|
|
EP1827438B2
(en)
|
2004-09-20 |
2014-12-10 |
Xenon Pharmaceuticals Inc. |
Piperazin derivatives for inhibiting human stearoyl-coa-desaturase
|
|
CN101084211A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
杂环衍生物及其作为治疗剂的用途
|
|
BRPI0515500A
(pt)
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados piridazina para inibição de estearoil-coa-desaturase
|
|
AU2005286728A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
|
|
MX2007003332A
(es)
|
2004-09-20 |
2007-06-05 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
|
|
US20070190079A1
(en)
*
|
2004-10-29 |
2007-08-16 |
Kalypsys, Inc. |
Methods for the selective modulation of ppar
|
|
CA2585172C
(en)
*
|
2004-10-29 |
2014-08-12 |
Kalypsys, Inc. |
Sulfonyl-substituted bicyclic compounds as modulators of ppar
|
|
WO2007047432A1
(en)
|
2005-10-12 |
2007-04-26 |
Kalypsys, Inc. |
Sulfonamide derivatives as modulators of ppar
|
|
WO2007047431A2
(en)
*
|
2005-10-12 |
2007-04-26 |
Kalypsys, Inc. |
Sulfonyl-substituted aryl compounds as modulators of peroxisome proliferator activated receptors
|
|
WO2007109577A1
(en)
*
|
2006-03-17 |
2007-09-27 |
Kalypsys, Inc. |
Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar
|
|
US20070249519A1
(en)
*
|
2006-04-20 |
2007-10-25 |
Kalypsys, Inc. |
Methods for the upregulation of glut4 via modulation of ppar delta in adipose tissue and for the treatment of disease
|
|
US20080004281A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Kalypsys, Inc. |
Methods for the modulation of crp by the selective modulation of ppar delta
|
|
WO2008043024A2
(en)
|
2006-10-04 |
2008-04-10 |
Kalypsys, Inc. |
Oral pharmaceutical formulation comprising a sulfonyl bicyclic modulator of ppar for the treatment of disease
|
|
US20080287477A1
(en)
*
|
2006-10-11 |
2008-11-20 |
Kalypsys, Inc. |
Novel Compounds as Modulators of Ppar
|
|
WO2008091863A1
(en)
*
|
2007-01-23 |
2008-07-31 |
Kalypsys, Inc. |
Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
|